← Open Payments lookup

CHARLES WILLITS: Open Payments

NPI 1154065134 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$652 in 30 payments from 11 companies in 2025. Trend: 2023 $116 · 2024 $456 · 2025 $652

Food & beverage: $652
CompanyPaymentsAmount
Amgen Inc.8$154
AstraZeneca Pharmaceuticals LP3$149
PFIZER INC.4$64
ABBVIE INC.3$61
Novo Nordisk Inc3$56
Sumitomo Pharma America, Inc.2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Viatris Specialty LLC2$31
Otsuka America Pharmaceutical, Inc.1$22
SHIELD THERAPEUTICS INC1$20

Products named: FARXIGA, OTEZLA, NURTEC ODT, VRAYLAR, GEMTESA, CAPLYTA, Ozempic, AIRSUPRA.

Industry payments across MO — which companies pay providers there.